Global Endometrial Cancer Market Growth (Status and Outlook) 2024-2030

May 2024 | 109 pages | ID: GB7560B606F1EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to Others parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Others symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.

The global Endometrial Cancer market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Endometrial Cancer Industry Forecast” looks at past sales and reviews total world Endometrial Cancer sales in 2023, providing a comprehensive analysis by region and market sector of projected Endometrial Cancer sales for 2024 through 2030. With Endometrial Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endometrial Cancer industry.

This Insight Report provides a comprehensive analysis of the global Endometrial Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endometrial Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endometrial Cancer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endometrial Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endometrial Cancer.

The endometrial cancer market is dominated by North America owing to the rising prevalence of breast cancer.

This report presents a comprehensive overview, market shares, and growth opportunities of Endometrial Cancer market by product type, application, key players and key regions and countries.

Segmentation by type

• Hysterectomy Techniques
• Radiation
• Hormone Therapy
• ChemOthersapy

Segmentation by application

• Hospitals
• Clinics
• Gynecology Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Johnson & Johnson
• Boston Scientific
• GE
• Karl Storz
• Koninklijke Philips
• Celgene
• Lupin
• LiNA Medical
• Bayer AG
• Cooper Surgical
• Hologic

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Endometrial Cancer Market Size 2019-2030
  2.1.2 Endometrial Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Endometrial Cancer Segment by Type
  2.2.1 Hysterectomy Techniques
  2.2.2 Radiation
  2.2.3 Hormone Therapy
  2.2.4 ChemOthersapy
2.3 Endometrial Cancer Market Size by Type
  2.3.1 Endometrial Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Endometrial Cancer Market Size Market Share by Type (2019-2024)
2.4 Endometrial Cancer Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Gynecology Centers
  2.4.4 Others
2.5 Endometrial Cancer Market Size by Application
  2.5.1 Endometrial Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Endometrial Cancer Market Size Market Share by Application (2019-2024)

3 ENDOMETRIAL CANCER MARKET SIZE BY PLAYER

3.1 Endometrial Cancer Market Size Market Share by Players
  3.1.1 Global Endometrial Cancer Revenue by Players (2019-2024)
  3.1.2 Global Endometrial Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Endometrial Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ENDOMETRIAL CANCER BY REGIONS

4.1 Endometrial Cancer Market Size by Regions (2019-2024)
4.2 Americas Endometrial Cancer Market Size Growth (2019-2024)
4.3 APAC Endometrial Cancer Market Size Growth (2019-2024)
4.4 Europe Endometrial Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Endometrial Cancer Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Endometrial Cancer Market Size by Country (2019-2024)
5.2 Americas Endometrial Cancer Market Size by Type (2019-2024)
5.3 Americas Endometrial Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Endometrial Cancer Market Size by Region (2019-2024)
6.2 APAC Endometrial Cancer Market Size by Type (2019-2024)
6.3 APAC Endometrial Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Endometrial Cancer by Country (2019-2024)
7.2 Europe Endometrial Cancer Market Size by Type (2019-2024)
7.3 Europe Endometrial Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Endometrial Cancer by Region (2019-2024)
8.2 Middle East & Africa Endometrial Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Endometrial Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ENDOMETRIAL CANCER MARKET FORECAST

10.1 Global Endometrial Cancer Forecast by Regions (2025-2030)
  10.1.1 Global Endometrial Cancer Forecast by Regions (2025-2030)
  10.1.2 Americas Endometrial Cancer Forecast
  10.1.3 APAC Endometrial Cancer Forecast
  10.1.4 Europe Endometrial Cancer Forecast
  10.1.5 Middle East & Africa Endometrial Cancer Forecast
10.2 Americas Endometrial Cancer Forecast by Country (2025-2030)
  10.2.1 United States Endometrial Cancer Market Forecast
  10.2.2 Canada Endometrial Cancer Market Forecast
  10.2.3 Mexico Endometrial Cancer Market Forecast
  10.2.4 Brazil Endometrial Cancer Market Forecast
10.3 APAC Endometrial Cancer Forecast by Region (2025-2030)
  10.3.1 China Endometrial Cancer Market Forecast
  10.3.2 Japan Endometrial Cancer Market Forecast
  10.3.3 Korea Endometrial Cancer Market Forecast
  10.3.4 Southeast Asia Endometrial Cancer Market Forecast
  10.3.5 India Endometrial Cancer Market Forecast
  10.3.6 Australia Endometrial Cancer Market Forecast
10.4 Europe Endometrial Cancer Forecast by Country (2025-2030)
  10.4.1 Germany Endometrial Cancer Market Forecast
  10.4.2 France Endometrial Cancer Market Forecast
  10.4.3 UK Endometrial Cancer Market Forecast
  10.4.4 Italy Endometrial Cancer Market Forecast
  10.4.5 Russia Endometrial Cancer Market Forecast
10.5 Middle East & Africa Endometrial Cancer Forecast by Region (2025-2030)
  10.5.1 Egypt Endometrial Cancer Market Forecast
  10.5.2 South Africa Endometrial Cancer Market Forecast
  10.5.3 Israel Endometrial Cancer Market Forecast
  10.5.4 Turkey Endometrial Cancer Market Forecast
  10.5.5 GCC Countries Endometrial Cancer Market Forecast
10.6 Global Endometrial Cancer Forecast by Type (2025-2030)
10.7 Global Endometrial Cancer Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Endometrial Cancer Product Offered
  11.1.3 Pfizer Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Endometrial Cancer Product Offered
  11.2.3 Johnson & Johnson Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 Boston Scientific
  11.3.1 Boston Scientific Company Information
  11.3.2 Boston Scientific Endometrial Cancer Product Offered
  11.3.3 Boston Scientific Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Boston Scientific Main Business Overview
  11.3.5 Boston Scientific Latest Developments
11.4 GE
  11.4.1 GE Company Information
  11.4.2 GE Endometrial Cancer Product Offered
  11.4.3 GE Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 GE Main Business Overview
  11.4.5 GE Latest Developments
11.5 Karl Storz
  11.5.1 Karl Storz Company Information
  11.5.2 Karl Storz Endometrial Cancer Product Offered
  11.5.3 Karl Storz Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Karl Storz Main Business Overview
  11.5.5 Karl Storz Latest Developments
11.6 Koninklijke Philips
  11.6.1 Koninklijke Philips Company Information
  11.6.2 Koninklijke Philips Endometrial Cancer Product Offered
  11.6.3 Koninklijke Philips Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Koninklijke Philips Main Business Overview
  11.6.5 Koninklijke Philips Latest Developments
11.7 Celgene
  11.7.1 Celgene Company Information
  11.7.2 Celgene Endometrial Cancer Product Offered
  11.7.3 Celgene Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Celgene Main Business Overview
  11.7.5 Celgene Latest Developments
11.8 Lupin
  11.8.1 Lupin Company Information
  11.8.2 Lupin Endometrial Cancer Product Offered
  11.8.3 Lupin Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Lupin Main Business Overview
  11.8.5 Lupin Latest Developments
11.9 LiNA Medical
  11.9.1 LiNA Medical Company Information
  11.9.2 LiNA Medical Endometrial Cancer Product Offered
  11.9.3 LiNA Medical Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 LiNA Medical Main Business Overview
  11.9.5 LiNA Medical Latest Developments
11.10 Bayer AG
  11.10.1 Bayer AG Company Information
  11.10.2 Bayer AG Endometrial Cancer Product Offered
  11.10.3 Bayer AG Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Bayer AG Main Business Overview
  11.10.5 Bayer AG Latest Developments
11.11 Cooper Surgical
  11.11.1 Cooper Surgical Company Information
  11.11.2 Cooper Surgical Endometrial Cancer Product Offered
  11.11.3 Cooper Surgical Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Cooper Surgical Main Business Overview
  11.11.5 Cooper Surgical Latest Developments
11.12 Hologic
  11.12.1 Hologic Company Information
  11.12.2 Hologic Endometrial Cancer Product Offered
  11.12.3 Hologic Endometrial Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Hologic Main Business Overview
  11.12.5 Hologic Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Endometrial Cancer Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Hysterectomy Techniques
Table 3. Major Players of Radiation
Table 4. Major Players of Hormone Therapy
Table 5. Major Players of ChemOthersapy
Table 6. Endometrial Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Endometrial Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Endometrial Cancer Market Size Market Share by Type (2019-2024)
Table 9. Endometrial Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Endometrial Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Endometrial Cancer Market Size Market Share by Application (2019-2024)
Table 12. Global Endometrial Cancer Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Endometrial Cancer Revenue Market Share by Player (2019-2024)
Table 14. Endometrial Cancer Key Players Head office and Products Offered
Table 15. Endometrial Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Endometrial Cancer Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Endometrial Cancer Market Size Market Share by Regions (2019-2024)
Table 20. Global Endometrial Cancer Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Endometrial Cancer Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Endometrial Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Endometrial Cancer Market Size Market Share by Country (2019-2024)
Table 24. Americas Endometrial Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Endometrial Cancer Market Size Market Share by Type (2019-2024)
Table 26. Americas Endometrial Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Endometrial Cancer Market Size Market Share by Application (2019-2024)
Table 28. APAC Endometrial Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Endometrial Cancer Market Size Market Share by Region (2019-2024)
Table 30. APAC Endometrial Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Endometrial Cancer Market Size Market Share by Type (2019-2024)
Table 32. APAC Endometrial Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Endometrial Cancer Market Size Market Share by Application (2019-2024)
Table 34. Europe Endometrial Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Endometrial Cancer Market Size Market Share by Country (2019-2024)
Table 36. Europe Endometrial Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Endometrial Cancer Market Size Market Share by Type (2019-2024)
Table 38. Europe Endometrial Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Endometrial Cancer Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Endometrial Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Endometrial Cancer Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Endometrial Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Endometrial Cancer Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Endometrial Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Endometrial Cancer Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Endometrial Cancer
Table 47. Key Market Challenges & Risks of Endometrial Cancer
Table 48. Key Industry Trends of Endometrial Cancer
Table 49. Global Endometrial Cancer Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Endometrial Cancer Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Endometrial Cancer Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Endometrial Cancer Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Pfizer Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 54. Pfizer Endometrial Cancer Product Offered
Table 55. Pfizer Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Johnson & Johnson Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 59. Johnson & Johnson Endometrial Cancer Product Offered
Table 60. Johnson & Johnson Main Business
Table 61. Johnson & Johnson Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Johnson & Johnson Latest Developments
Table 63. Boston Scientific Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 64. Boston Scientific Endometrial Cancer Product Offered
Table 65. Boston Scientific Main Business
Table 66. Boston Scientific Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Boston Scientific Latest Developments
Table 68. GE Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 69. GE Endometrial Cancer Product Offered
Table 70. GE Main Business
Table 71. GE Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. GE Latest Developments
Table 73. Karl Storz Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 74. Karl Storz Endometrial Cancer Product Offered
Table 75. Karl Storz Main Business
Table 76. Karl Storz Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Karl Storz Latest Developments
Table 78. Koninklijke Philips Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 79. Koninklijke Philips Endometrial Cancer Product Offered
Table 80. Koninklijke Philips Main Business
Table 81. Koninklijke Philips Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Koninklijke Philips Latest Developments
Table 83. Celgene Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 84. Celgene Endometrial Cancer Product Offered
Table 85. Celgene Main Business
Table 86. Celgene Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Celgene Latest Developments
Table 88. Lupin Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 89. Lupin Endometrial Cancer Product Offered
Table 90. Lupin Main Business
Table 91. Lupin Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Lupin Latest Developments
Table 93. LiNA Medical Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 94. LiNA Medical Endometrial Cancer Product Offered
Table 95. LiNA Medical Main Business
Table 96. LiNA Medical Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. LiNA Medical Latest Developments
Table 98. Bayer AG Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 99. Bayer AG Endometrial Cancer Product Offered
Table 100. Bayer AG Main Business
Table 101. Bayer AG Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bayer AG Latest Developments
Table 103. Cooper Surgical Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 104. Cooper Surgical Endometrial Cancer Product Offered
Table 105. Cooper Surgical Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Cooper Surgical Main Business
Table 107. Cooper Surgical Latest Developments
Table 108. Hologic Details, Company Type, Endometrial Cancer Area Served and Its Competitors
Table 109. Hologic Endometrial Cancer Product Offered
Table 110. Hologic Main Business
Table 111. Hologic Endometrial Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Hologic Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Endometrial Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endometrial Cancer Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Endometrial Cancer Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Endometrial Cancer Sales Market Share by Country/Region (2023)
Figure 8. Endometrial Cancer Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Endometrial Cancer Market Size Market Share by Type in 2023
Figure 10. Endometrial Cancer in Hospitals
Figure 11. Global Endometrial Cancer Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Endometrial Cancer in Clinics
Figure 13. Global Endometrial Cancer Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Endometrial Cancer in Gynecology Centers
Figure 15. Global Endometrial Cancer Market: Gynecology Centers (2019-2024) & ($ Millions)
Figure 16. Endometrial Cancer in Others
Figure 17. Global Endometrial Cancer Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Endometrial Cancer Market Size Market Share by Application in 2023
Figure 19. Global Endometrial Cancer Revenue Market Share by Player in 2023
Figure 20. Global Endometrial Cancer Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Endometrial Cancer Market Size 2019-2024 ($ Millions)
Figure 22. APAC Endometrial Cancer Market Size 2019-2024 ($ Millions)
Figure 23. Europe Endometrial Cancer Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Endometrial Cancer Market Size 2019-2024 ($ Millions)
Figure 25. Americas Endometrial Cancer Value Market Share by Country in 2023
Figure 26. United States Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Endometrial Cancer Market Size Market Share by Region in 2023
Figure 31. APAC Endometrial Cancer Market Size Market Share by Type in 2023
Figure 32. APAC Endometrial Cancer Market Size Market Share by Application in 2023
Figure 33. China Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Endometrial Cancer Market Size Market Share by Country in 2023
Figure 40. Europe Endometrial Cancer Market Size Market Share by Type (2019-2024)
Figure 41. Europe Endometrial Cancer Market Size Market Share by Application (2019-2024)
Figure 42. Germany Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Endometrial Cancer Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Endometrial Cancer Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Endometrial Cancer Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Endometrial Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 56. APAC Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 57. Europe Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 59. United States Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 60. Canada Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 63. China Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 64. Japan Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 65. Korea Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 67. India Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 68. Australia Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 69. Germany Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 70. France Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 71. UK Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 72. Italy Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 73. Russia Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 74. Spain Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 77. Israel Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Endometrial Cancer Market Size 2025-2030 ($ Millions)
Figure 80. Global Endometrial Cancer Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Endometrial Cancer Market Size Market Share Forecast by Application (2025-2030)